Cerebellar network alterations in adult attention-deficit/hyperactivity disorder
Journal of Psychiatry and Neuroscience · 2024
DOI: 10.1503/jpn.230146 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Psychiatry and Neuroscience, 2024. Verfasst von Salla Parkkinen und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Institute of Translational Neurodevelopment, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and…. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Cerebellum, Diffusion Tensor Imaging, Methylphenidate. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that often persists into adulthood. Underlying alterations in brain connectivity have been identified but some relevant connections, such as the middle, superior, and inferior cerebellar peduncles (MCP, SCP, and ICP, respectively), have remained largely unexplored; thus, we sought to investigate whether the cerebellar peduncles contribute to ADHD pathophysiology among adults.
Methods
We applied diffusion-weighted spherical deconvolution tractography to dissect the cerebellar peduncles of male adults with ADHD (including those who did or did not respond to methylphenidate, based on at least 30% symptom improvement at 2 months) and controls. We investigated differences in tract metrics between controls and the whole ADHD sample and between controls and treatment-response groups using sensitivity analyses. Finally, we analyzed the association between the tract metrics and cliniconeuropsychological profiles.
Results
We included 60 participants with ADHD (including 42 treatment responders and 18 nonresponders) and 20 control participants. In the whole ADHD sample, MCP fractional anisotropy (FA; t 78 = 3.24, p = 0.002) and hindrance modulated orientational anisotropy (HMOA; t 78 = 3.01, p = 0.004) were reduced, and radial diffusivity (RD) in the right ICP was increased ( t 78 = −2.84, p = 0.006), compared with controls. Although case–control differences in MCP FA and HMOA, which reflect white-matter microstructural organization, were driven by both treatment response groups, only responders significantly differed from controls in right ICP RD, which relates to myelination ( t 60 = 3.14, p = 0.003). Hindrance modulated orientational anisotropy of the MCP was significantly positively associated with hyperactivity measures.
Limitations
This study included only male adults with ADHD. Further research needs to investigate potential sex- and development-related differences.
Conclusion
These results support the role of the cerebellar networks, especially of the MCP, in adult ADHD pathophysiology and should encourage further investigation. Clinical trial registration: NCT 03709940
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Institute of Translational Neurodevelopment, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK (Parkkinen, Andrews,…
Zitieren
APA
Parkkinen, S., Radua, J., Andrews, D. S., Murphy, D., Dell'Acqua, F., & Parlatini, V. (2024). Cerebellar network alterations in adult attention-deficit/hyperactivity disorder. Journal of Psychiatry and Neuroscience. https://doi.org/10.1503/jpn.230146
Vancouver
Parkkinen S, Radua J, Andrews DS, Murphy D, Dell'Acqua F, Parlatini V. Cerebellar network alterations in adult attention-deficit/hyperactivity disorder. Journal of Psychiatry and Neuroscience. 2024. doi:10.1503/jpn.230146
BibTeX
@article{Parkkinen2024,
author = {Parkkinen, Salla and Radua, Joaquim and Andrews, Derek S and Murphy, Declan and Dell'Acqua, Flavio and Parlatini, Valeria},
title = {Cerebellar network alterations in adult attention-deficit/hyperactivity disorder},
journal = {Journal of Psychiatry and Neuroscience},
year = {2024},
doi = {10.1503/jpn.230146}
}
EUVIMED